SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021923
Filing Date
2022-11-03
Accepted
2022-11-03 16:31:19
Documents
80
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-20220930.htm   iXBRL 10-Q 3658023
2 EX-31.1 adpt-ex31_1.htm EX-31.1 23831
3 EX-31.2 adpt-ex31_2.htm EX-31.2 24307
4 EX-32.1 adpt-ex32_1.htm EX-32.1 14548
5 EX-32.2 adpt-ex32_2.htm EX-32.2 16404
  Complete submission text file 0000950170-22-021923.txt   11418061

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adpt-20220930_pre.xml EX-101.PRE 365677
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adpt-20220930_cal.xml EX-101.CAL 51769
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adpt-20220930_lab.xml EX-101.LAB 472551
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adpt-20220930_def.xml EX-101.DEF 198348
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adpt-20220930.xsd EX-101.SCH 63259
74 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20220930_htm.xml XML 2298425
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 221358553
SIC: 2836 Biological Products, (No Diagnostic Substances)